Purchase Order 75N92E25P00012

This is a firm fixed price purchase order awarded by the National Human Genome Research Institute, a civilian agency, to Tecan Genomics, Inc., a Switzerland-based manufacturer of life science laboratory automation and detection solutions. The $14,392.50 contract is to obtain a 3-month supply of reagents to identify SARS-CoV-2 variants in patient samples for the Vaccine Research Center (VRC). The award has no set-aside designation and the performance period runs through November 30, 2024. Tecan Genomics has provided similar automation equipment, reagents, and sequencing services to support infectious disease, genome, and aging research programs at the National Institutes of Health and the Centers for Disease Control and Prevention under prior federal contract awards.